- (
) Trade Talk: Hospice doctor to study Alzheimer's disease
Dr. John Thomas, medical director for Hospice of the Red River Valley, is among 20 people named to do research and give input on Alzheimer's disease. Word count: 431
To continue reading the full text, purchase this article or subscribe to PressPassYou must be logged in to purchase articles. Sign in below or create an account.
Log In . More>> - (
) Medivation (MDVN): Drug firm targets Alzheimer's
In his Xcelerated Profits Report, the advisor explains, "Medivation continues to make good clinical trial progress with its Dimebon drug for Alzheimer's Disease."The firm received some mainstream media attention at the recent International Conference on Alzheimer's Disease (ICAD) in Vienna. Reuters, Forbes and Bloomberg all reported that Dimebon is changing the way scientists think about Alzheimer's.
. More>> - (
) 'When mom turned a stranger'
But Alzheimer's has changed all that in the last six years. Though physically present with us, she has atrophied mentally and has drifted far away to a space and time we cannot penetrate — to an unreal world where she has no identity and where we don't belong.As the disease progressed, every day brought in changes in her personality and behaviour — some alarming, others agonising to watch — but all so far removed from the person that she is. The doctors had prepared us for a time when her cognitive skills would get so eroded that she would fail to recognise even us, her family. But when that did happen and her mind just shut us out, it crushed us, to say the least. It was a moment of complete helplessness.
I am still grappling with the loss of that beautiful relationship which I have realised can never be matched. More>>
- (
) Octapharma Aims to Expand US Immune Globulin Therapy Portfolio
Octagam is currently being investigated in clinical trials studying the efficacy of treatment for CIDP, ITP, multiple sclerosis, Alzheimer's disease and primary immune deficiency. In February, Octapharma started phase II clinical trials following FDA review of its IND for octagam 10% in mild-to-moderate Alzheimer's disease.Octapharma AG
Headquartered in Lachen, Switzerland, Octapharma is the third largest plasma products manufacturer in the world and has been committed to patient care and medical innovation for over 25 years. Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell lines, including immune globulin intravenous (IGIV). In the U.S., Octapharma's IGIV product, octagam(R) (immune globulin intravenous [human] 5%), is used to treat disorders of the immune system, and Octapharma's Albumin (Human) is indicated for the restoration and maintenance of circulating blood volume. More>>
- (
) Brooke Astor's Alzheimers kept her from knowing she signed away
There is no way the Alzheimer's-stricken Astor knew what she was doing when she gave $60 million earmarked for charity to Anthony Marshall, the prosecutor said in another day of closing arguments in Marshall's marathon trial.Marshall, 85, and lawyer Francis Morrissey, 66, are accused of ripping off Astor by duping her into signing the legal papers in a 2004 closed-door meeting.
"She didn't know what was happening when she went into the meeting and she didn't know what was happening when she was going out," Assistant District Attorney Joel Seidemann said.
Seidemann told the jury that a long list of Astor's good friends - among them former Secretary of State Henry Kissinger and journalist Barbara Walters - testified that she was never lucid around them. More>>